Results 131 to 140 of about 79,060 (245)

Letter to the Editor in response to the article “Association between thyroid dysfunction and cognitive impairment in type 2 diabetes mellitus: A cross‐sectional study”

Journal of Diabetes Investigation, EarlyView.
Qun Fang
wiley   +1 more source

Baclofen Misuse in Clinical Practice: A Case Report on Management Strategies

Clinical Case Reports, Volume 14, Issue 7, July 2026.
ABSTRACT Baclofen, a GABA_B receptor agonist, is increasingly linked to misuse and severe withdrawal symptoms, including acute neuropsychiatric manifestations. We present a 26‐year‐old male exhibiting severe substance use disorder and recurrent depressive episodes, accompanied by profound insomnia, suicidal ideation, and visual hallucinations.
Mostafa Yousef, Mohamed Elsayed, Ahmed Hosney Nada, Olivier Uwishema   +3 more
wiley   +1 more source

<i>Helicobacter pylori</i> infection and the hypothalamic-pituitary axis: association with cortisol and thyroid-stimulating hormone levels in adults. [PDF]

Iran J Microbiol
Husein N, Abbas MM, Basha D, Owais DT, Hanineh-Halasa NA.   +4 more
europepmc   +1 more source

A Prospective Evaluation of Glucagon Stimulation Test Safety in Adults With Chronic Moderate‐to‐Severe Traumatic Brain Injury

Endocrinology, Diabetes &Metabolism, Volume 9, Issue 4, July 2026.
The glucagon stimulation test demonstrates a favourable safety profile in adults with chronic moderate‐to‐severe traumatic brain injury, with transient, non‐severe adverse effects and no serious complications. ABSTRACT Introduction Growth hormone deficiency (GHD) is a common and clinically significant consequence of moderate‐to‐severe traumatic brain ...
Corey Snyder, Emily Hillaker, Justin Weppner   +2 more
wiley   +1 more source

Preconception body mass index and maternal thyroid function: a longitudinal observational study. [PDF]

Eur Thyroid J
Moleti M, Alibrandi A, Crupi L, Paola G, Perdichizzi LG, Balbo L, Marchese S, Sgrò G, D'Anna S, Ragonese M, Granese R, Vermiglio F, Cannavò S.   +12 more
europepmc   +1 more source

Taste and Smell Disturbances Associated With Secondary Adrenal Insufficiency: A Case Report

Journal of General and Family Medicine, Volume 27, Issue 4, July 2026.
ABSTRACT Background Adrenal insufficiency often presents with nonspecific symptoms, impeding early diagnosis. Taste and smell disturbances are rarely recognized as presenting features. Case Presentation We report the case of a 54‐year‐old man with a 3‐month history of persistent taste and smell disturbances accompanied by fatigue, loss of appetite ...
Takanori Izumi, Eri Doi, Yuki Tsutsui, Noboru Horinouchi, Rie Utsunomiya, Katsuhiko Yoshimura, Machiko Morita, Naoki Matsuda, Seiji Shiota   +8 more
wiley   +1 more source

Thyroid hormones and energy metabolism in amyotrophic lateral sclerosis. [PDF]

Brain Commun
Novikova L, Lang C, Tumani H, Klose V, Kassubek J, Dreyhaupt J, Dupuis L, Wabitsch M, Ludolph A.   +8 more
europepmc   +1 more source

What Is Your Diagnosis? Superficial Cervical Lymph Node Cytology

Veterinary Clinical Pathology, EarlyView.
Vinicius N. Hirata, Rúbia S. da Silva, Francisca B. Lang, Augusto de Oliveira, Cinthia M. de Andrade   +4 more
wiley   +1 more source

Vitamin‐Responsive Disorders: From Molecular Basis to Clinical Presentation and Therapy

Journal of Inherited Metabolic Disease, Volume 49, Issue 4, July 2026.
ABSTRACT Vitamin‐dependent cofactors are essential for numerous metabolic reactions, and defects affecting their uptake, conversion, utilisation, or regeneration constitute a heterogeneous group of inherited metabolic disorders (IMDs). Although dietary vitamin intake is sufficient to sustain coenzyme synthesis in healthy individuals, it is insufficient
Cécile Acquaviva, Yann Nadjar, Manuel Schiff, Christine Vianey‐Saban, Alain Fouilhoux, Jean‐François Benoist   +5 more
wiley   +1 more source

A Phase II Trial of Perioperative Camrelizumab Plus Neoadjuvant Chemotherapy in Resectable Stage IIB–IIIB Lung Squamous Cell Carcinoma

MedComm, Volume 7, Issue 7, July 2026.
This phase II trial suggests the potential of perioperative camrelizumab plus neoadjuvant chemotherapy in patients with resectable stage IIB‐IIIB lung squamous cell carcinoma. The major pathological response rate (primary endpoint) was 60.0%, and the pathological complete response (pCR) rate was 44.4%.
Mingming Hu, Shuku Liu, Yi Han, Feng Wang, Yang Liu, Baohua Lu, Hongxia Li, Yuan Gao, Ying Wang, Wei Yang, Kang Shi, Bo Xiao, Qunhui Wang, Juan Du, Haifeng Lin, Xiaomi Li, Chong Wang, Tongmei Zhang   +17 more
wiley   +1 more source